12 August 2026
Chinese researchers may have found a way to reverse childhood myopia using nothing but red light, and the clinical results are already reshaping how the world thinks about corrective lenses.
This video breaks down Repeated Low-Level Red Light therapy (RLRL), a three-minute daily treatment developed at the Zhongshan Ophthalmic Center in Guangzhou that reduced eyeball elongation by nearly 70 percent in a randomized clinical trial, with some children's eyes actually shortening. We explain the science of photobiomodulation, how red light boosts blood flow to the sclera to stop the eye from stretching, and why myopia rates have exploded to over 80 percent among Chinese high schoolers.
You'll learn about the Eyerising device now approved in the UK, EU, Japan, and Australia, why it still isn't FDA-approved in the US, the safety concerns that led China to reclassify these devices, and how low-dose atropine eye drops are emerging as a second major treatment. We also cover why the global eyewear industry has little incentive to fund a cure for the condition it profits from. If you or your child wears glasses, this is the future of myopia treatment you need to understand.
